Endocrinology of male infertility: Evaluation and treatment

Seminars in Reproductive Medicine

Volumn 27, Issue 2, 2009, Pages 149-158

  Sokol, Rebecca Z ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WOMEN S AND CHILDREN S HOSPITAL   (United States)

Author keywords

Follicle stimulating hormone; Hypogonadism; Luteinizing hormone; Male infertility; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; CHORIONIC GONADOTROPIN; CLOMIFENE; G PROTEIN COUPLED RECEPTOR; GONADORELIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; SEX HORMONE BINDING GLOBULIN; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TESTOSTERONE ENANTATE;

ADULTHOOD; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; BEHAVIOR CHANGE; CHRONIC DISEASE; CONGENITAL ADRENAL HYPERPLASIA; CONTINUOUS INFUSION; CRANIOPHARYNGIOMA; CRYPTORCHISM; DIFFERENTIAL DIAGNOSIS; EVALUATION; FOLLITROPIN BLOOD LEVEL; GENETIC VARIABILITY; HEMISPHERIC DOMINANCE; HERITABILITY; HORMONAL THERAPY; HORMONE RESISTANCE; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS ADENOMA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; KLINEFELTER SYNDROME; LEFT HEMISPHERE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MALE INFERTILITY; NEUROPSYCHOLOGICAL TEST; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; PREPUBERTY; SPERMATOGENESIS; SPERMATOZOON COUNT; TESTIS ATROPHY; TESTIS DISEASE; TESTIS TORSION; TESTOSTERONE BLOOD LEVEL; THERAPY EFFECT; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; TREATMENT RESPONSE;

DIAGNOSIS, DIFFERENTIAL; ENDOCRINE GLANDS; ENDOCRINE SYSTEM DISEASES; HUMANS; INFERTILITY, MALE; MALE;

EID: 63449113714     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0029-1202303     Document Type: Article

References (85)

1. Sokol RZ, Swerdloff RS. Endocrine evaluation. In: Lipshultz LI, Howards ST, eds. Infertility in the Male, Third ed. St.' Louis, MO: Mosby-Year Book; 1997:10-18
2. Bilezikjian LM, Blountal AL, Leal AM, Donaldson CJ, Fischer WH, Vale WW. Autocrine/paracrine regulation of pituitary function by activin, inhibin, and follistatin. Mol Cell Endocrinol 2004;225:29-36
3. Gillani MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas, Endocr Rev 2006;27; 485-534
4. Wilson JD, Griffin JE, Russell DW. Steroid 5α-reductase 2 deficiency. Endocr Rev 1993;14:577-593
5. Hughes IA, Mini-review: sex differentiation. Endocrinology 2001;142:3281-3287
6. Longcope C, Sato K, McKay C, Horton R. Aromatization by splanchnic tissue in men. J Clin Endocrinol Metab 1984; 58:1089-1093
7. Ismail AA, Barth JH. Endocrinology of gynecomastia. Ann Clin Biochem 2001;38:596-607
8. Petersen C, Soder O. The Sertoli cell - a hormonal target and 'super' nurse for germ cells that determines testicular size. Horm Res 2006;66:153-161
9. Holsberger DR, Cooke PS. Understanding the role of thyroid hormone in Sertoli cell development: a mechanistic hypothesis. Cell Tissue Res 2005;322:133-140
10. de Kretser DM, Buzzard JJ, Okuma Y, et al. The role of activin, follistatin and inhibin in testicular physiology. Mol Cell Endocrinol 2004;225:57-64
11. Kolb B A, Stanczyk FZ, Sokol RZ, Serum inhibin B levels in males with gonadal dysfunction. Fertil Steril 2000;74:234-238
12. Tong S, Wallace EM, Burger HG. Inhibins and activins: clinical advances in reproductive medicine. Clin Endocrinol (Oxf) 2003;58:115-127
13. Jarow JP, Zirkin BR, The androgen microenvironment of the human testis and hormonal control of spermatogenesis. Ann N Y Acad Sci 2005;1061:208-220
14. Bain J, Langevin R, D'Costa M, Sanders RM, Hucker S. Serum pituitary and steroid hormone levels in the adult male: one value is as good as the mean of three, Fertil Steril 1988;49:123-126
15. Vermeiden A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84: 3666-3672
16. Wang C, Catlin DH, Deniers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromoatography-tandem mass spectrometry. J Clin Endocrinol Metab 2004;89:534-543
17. Handelsman DJ. Update in andrology. J Clin Endocrinol Metab 2007;92:4505-4511
18. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone; an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:405-413
19. Carruthers M. Androgen Deficiency in the Adult Male: Causes, Diagnosis and Treatment. London, England: Taylor & Francis; 2004
20. Harman SM, Metter Ej, Tobin JD, Pearson J, Blackmail MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001;86:724-731
21. Melmed S, Update in pituitary disease. J Clin Endocrinol Metab 2008;93:331-338
22. Trarbach EB, Baptista MTM, Garnies HM, Hackel C. Molecular analysis of KAL-1, GnRH-R, NELF and EBF2 genes in a series of Kallmann syndrome and normosmic hypogonadotropic hypogonadism patients, J Endocrinol 2005; 187:361-368
23. Bhagavath B, Podolsky RH, Ozata M, et al. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism, Fertil Steril 2006;85: 706-713
24. Nachtigall LB, Boepple PA, Pralong FP, Crowley WF Jr. Adult-onset idiopathic hypogonadotropic hypogonadism - a treatable form of male infertility. N Engl J Med 1997;336: 410-415
25. Goldstone AP, Beales PL. Genetic obesity syndromes. Front Horm Res 2008;36:37-60
26. Giltay JC, Deege M, Blankenstein RA, Kastrop PMM, Wijmenga C, Lock TTWT. Apparent primary follicle-stimulating hormone deficiency is a rare cause of treatable male infertility. Fertil Steril 2004;81:693-696
27. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998;89:547-551
28. Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas, Endocr Rev 2006;27:371-397
29. Murialdo G, Tamagno G. Endocrine aspects of neuro-sarcoidosis. J Endocrinol Invest 2002;25:650-662
30. Lewis ASCommentStCommentEndCommentBody. Courtney CH, Atkinson AB. All patients with 'idiopathic' hypopituitarism should be screened for hemochromatosis. Pituitary 2008; February 13 (Epub ahead of print)
31. Bayrak A, Saadat P, Mor E, Chong L, Paulson RJ, Sokol RZ. Pituitary imaging is indicated for the evaluation of hyperprolactinemia. Fertil Steril 2005;84:181-185
32. Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 2007;156:203-216
33. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA 2007;298:1429-1438
34. Maiya B, Newcombe V, Nortje J, et al. Magnetic resonance imaging changes in the pituitary gland following acute traumatic brain injury. Intensive Care Med 2008;34: 468-475
35. Spratt DI, Cox P, Orav J, Moloney J, Bigos T, Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metab 1993;76:1548-1554
36. Ding EL, Song Y, Malik VS, Li S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006;295:1288-1299
37. Goodman-Gruen D, Barrett-Connor E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 2000;23:912-918
38. Hammoud AO, Gibson M, Peterson CM, Hamilton BD, Carrell DT. Obesity and male reproductive potential. J Androl 2006;27:619-626
39. Catlin DH, Cowan DA, de la Torre R, et al. Urinary testosterone (T) to epitestosterone (E) ratios by GC/MS. I. Initial comparison of uncorrected T/E in six international laboratories. J Mass Spectrom 1996;31:397-402
40. Stikkelbroeck NM, Otten BJ, Pasic A, et al. High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001;86:5721-5728
41. Ghazi AA, Hadayegh F, Khakpour G, Azizi F, Melby JC. Bilateral testicular enlargement due to adrenal remnant in a patient with C11 hydroxylase deficiency congenital adrenal hyperplasia. J Endocrinol Invest 2003;26:84-87
42. Bojesen A, Juul S, Gravholt CH. Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab 2003;88:622-626
43. Simpson JL, de la Cruz F, Swerdloff RS, et al. Klinefelter syndrome: expanding the phenotype and identifying new research directions. Genet Med 2003;5:460-468
44. Thomas NS, Hassold TJ. Aberrant recombination and the origin of Klinefelter syndrome, Hum Reprod Update 2003;9: 309-317
45. Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E. Klinefelter's syndrome. Lancet 2004;364:273-283
46. Kamischke A, Baumgardt A, Horst J, Nieschlag E, Clinical and diagnostic features of patients with suspected Klinefelter syndrome. J Androl 2003;24:41-48
47. Vernaeve V, Staessen C, Verheyen G, Van Steirteghem A, Devroey P, Tournaye H. Can biological or clinical parameters predict testicular sperm recover)' in 47,XXY Klinefelter's syndrome patients? Hum Reprod 2004;19:1135-1139
48. Bojesen A, Juul S, Birkebaek NH, Gravholt CH. Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab 2006;91:1254-1260
49. Swerdlow AJ, Hermon C, Jacobs PA, et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet 2001;65: 177-188
50. Geschwind DH, Boone KB, Miller BL, Swerdloff RS. Neurobehavioral phenotype of Klinefelter syndrome. Ment Retard Dev Disabil Res Rev 2000;6:107-116
51. Ross JL, Roeltgen DP, Stefanatos G, et al. Cognitive and motor development during childhood in boys with Klinefelter syndrome. Am J Med Genet A 2008;146A:708-719
52. Hasle H, Mellemgaard A, Nielsen J, Hansen J. Cancer incidence in men with Klinefelter syndrome. Br J Cancer 1995;71:416-420
53. Hultborn R, Hanson C, Kopf I, Verbiené I, Warnhammar E, Weimarck A. Prevalence of Klinefelter's syndrome in male breast cancer patients. Anticancer Res 1997;17:4293-4297
54. Lue Y, Jentsch JD, Wang C, et al. XXY mice exhibit gonadal and behavioral phenotypes similar to Klinefelter syndrome. Endocrinology 2005;146:4148-4154
55. Meschede D, Horst J. The molecular genetics of male infertility. Mol Hum Reprod 1997;3:419-430
56. Cilento BG, Atala A. Cryptorchidism, testicular torsion, and torsion of testicular appendages. In: Kandeel FR, ed. Male Reproductive Dysfunction: Pathophysiology and Treatment. New York, NY, and London, England: Informa Healthcare; 2007:161-171
57. Hauser R, Sokol R. Science linking environmental contaminant exposures with fertility and reproductive health impacts in the adult male, Fertil Steril 2008;89(Suppl 1);e59-e65
58. Marchetti F, Wyrobek AJ, Mechanisms and consequences of paternally-transmitted chromosomal abnormalities. Birth Defects Res C Embryo Today 2005;75:112-129
59. Dowsing AT, Yong EL, Clark M, McLachlan RI, de Kretser DM, Trounson AO, Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet 1999;354:640-643
60. Griffin JE. Androgen resistance - the clinical and molecular spectrum. N Engl J Med 1992;326:611-618
61. Davis-Dao CA, Tuazon ED, Sokol RZ, Cortessis VK. J Clin Endocrinol Metab 2007;92:4319-4326
62. Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 1985;313:651-655
63. Sokol RZ. Male factor infertility. In; Lobo RA, Mishell DR Jr, Paulson RJ, Shoupe D, eds. Infertility, Contraception, and Reproductive Endocrinology. Fourth ed. Maiden, MA: Blackwell Science; 1997:547-566
64. Bouloux PM, Nieschlag E, Burger HG, et al. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl 2003;24:604-611
65. Bouloux P, Warne DW, Loumaye E, Study FSH. Group in Men's Infertility. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertil Steril 2002;77:270-273
66. Attia AM, Al-Inany HG, Proctor ML. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 2006;1:CD005071
67. Fukagai T, Kurosawa K, Sudo N, et al. Bilateral testicular tumors in an infertile man previously treated with follicle-stimulating hormones. Urology 2005;65:592.e16-592.e18
68. Liu PY, Handelsman DJ. The present and future state of hormonal treatment for male infertility, Hum Reprod Update 2003;9:9-23
69. Liu PY, Turner L, Rushford D, McDonald J, Baker HW, Conway AJ. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Hum Reprod 1999;14:1540-1545
70. Sokol RZ, McClure RD, Peterson M, Swerdloff RS. Gonadotropin therapy failure secondary to human chorionic gonadotropin-induced antibodies. J Clin Endocrinol Metab 1981;52:929-932
71. Whitten SJ, Nangia AK, Kolettis PN. Select patients with hypogonadotropic hypogonadism may respond to treatment with clomiphene citrate, Fertil Steril 2006;86:1664-1668
72. Hoffman AR, Crowley WF Jr. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med 1982;307:1237-
73. Kliesch S, Behre HM, Nieschlag E, High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol 1994;131:347-354
74. Skarin G, Nillius SJ, Wibell L, Wide L. Chronic pulsatile low dose GnRH therapy for induction of testosterone production and spermatogenesis in a man with secondary hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1982;55:723-726
75. Hammar M, Berg AA, Long term androgen replacement therapy does not preclude gonadotrophin-induced improve- ment on spermatogenesis. Scand J Urol Nephrol 1990; 24:17-19
76. Ley SB, Leonard JM. Male hypogonadotropic hypogonadism. Factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior endogenous androgens, J Clin Endocrinol Metab 1985;61:746-752
77. Schiff JD, Palermo GD, Veeck LL, Goldstein M, Rosenwaks Z, Schlegel PN. Success of testicular sperm injection and intracytoplasmic sperm injection in men with Klinefelter syndrome. J Clin Endocrinol Metab 2005;90:6263-6267
78. Zitzmann M, Nordhoff V, von Schonfeld V, et al. Elevated follicle-stimulating hormone levels and the chances for azoospermic men to become fathers after retrieval of elongated spermatids from cryopreserved testicular tissue. Fertil Steril 2006;86:339-347
79. Foresta C, Bettella A, Garolla A, Ambrosini G, Ferlin A. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study, Fertil Steril 2005;84:65-4-661
80. Hauser R, Temple-Smith PD, Southwick GJ, de Kretser D. Fertility in cases of hypergonadotropic azoospermia. Fertil Steril 1995;63:631-636
81. Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men, J Urol 2001 ;165: 837-841
82. Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol 2002;167:624-629
83. Sokol RZ, Palacios A, Campfield LA, Saul C, Swerdloff RS. Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal men. Fertil Steril 1982;37:425-430
84. Meikle AW, Arver S, Dobs AS, Sanders SW, Rajaram L, Mazer NA. Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site - a clinical research center study. J Clin Endocrinol Metab 1996;81:1832-1840
85. Swerdloff RS, Wang C, Cunningham G, et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 2000;85:4500-4510